Nationwide shortage hits prescription painkillers in Canada
In a recent development, Health Canada has issued a notice about a shortage of prescription pain medications containing acetaminophen with codeine or oxycodone, affecting common combination products like Percocet (acetaminophen with oxycodone) and Tylenol No. 3 (acetaminophen with codeine). The shortage is expected to last until early August, with a significant resupply anticipated.
Pharmacists and other healthcare providers are responding to the shortage by rationing supplies, splitting doses, and seeking supplies from other pharmacies. While direct alternatives to these combinations are currently scarce, patients can consider non-opioid pain relievers like acetaminophen alone (Tylenol) or non-steroidal anti-inflammatory drugs (NSAIDs, e.g., ibuprofen) for mild to moderate pain relief.
Other opioid alternatives and non-pharmacological methods or adjuvant analgesics may also be considered by prescribing physicians. The Canadian Pharmacists Association is working with Health Canada, manufacturers, and suppliers to assess the potential impact of the shortages.
Due to the Controlled Drugs and Substances Act, pharmacists cannot change a prescription or offer an alternative without consulting the physician to approve the suggestion. Patients experiencing pain during this time should consult their healthcare providers or pharmacists for personalized alternatives and management plans.
Health Canada urges Canadians to speak with their doctor or pharmacist if they have concerns about the availability of either medication. It is also advisable to only use a licensed pharmacy to get medication and only buy products authorized for sale in Canada. Canadians should avoid buying from unlicensed and unverified online sellers, as the products may not contain the active ingredient or contain undeclared and hazardous ingredients.
Companies like Teva Canada Ltd., Laboratoire Riva Inc., and Pharmascience Inc. have reported manufacturing disruptions and increased demands as causes of the shortages. Other formulations include Teva-Oxycocet, Teva-Lenoltic No. 1, 2, 3, and 4, and Rivacocet.
In summary, the shortage of prescription pain medications containing acetaminophen with codeine or oxycodone is a significant issue in Canada. Patients and healthcare providers are advised to work together to manage pain effectively until supplies normalize.
Science has shown that the current shortage of prescription pain medications, affecting health-and-wellness products like Percocet and Tylenol No. 3, can lead to mental-health issues, such as increased stress levels and anxiety, for those suffering from chronic pain. Therefore, it's crucial for Canadians to cooperate with their healthcare providers to find alternative pain relief options and manage their health effectively during this time.
